ESTA

Establishment Labs Holdings Inc.

Healthcare
Medical - Devices
$2.09B market cap

Forecast run · Sep 14, 2026Upside rank 1257 of 3,136

Model Signal

ForecastQ Daily Probabilities

40.1%

35.0%

15.3%

Analyst Consensus

Recommendation2.07/5 Buy

Last price$70.94

Price target$102.00

Implied move+43.8%

Analysts14

ForecastQ Portfolios

ESTA is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.